| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/07/2011 | US7956075 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/07/2011 | US7956072 Agent for repairing corneal sensitivity containing amide compound |
| 06/07/2011 | US7956050 Psychological disorders; analgesics; hyperactivity; eating disorders |
| 06/07/2011 | US7956035 Administering high density lipoprotein |
| 06/07/2011 | US7956030 Method for reducing pain with ziconotide and baclofen |
| 06/07/2011 | US7955622 core comprising a water insoluble polymer and acetylcholinesterase inhibitor, a release rate controlling coatings is surrounding the core including a release retarding excipient; administered less frequently, provide more stable blood levels; improve pharmacokinetic; dementia, mania, nicotine dependence |
| 06/07/2011 | US7955619 Abuse resistant drugs, method of use and method of making |
| 06/07/2011 | US7955618 Composition for treatment of inflammatory disorders |
| 06/07/2011 | US7955614 Microfabricated nanopore device for sustained release of therapeutic agent |
| 06/07/2011 | CA2785233A1 .beta.-carbolines for treatment of hearing damages and vertigo |
| 06/07/2011 | CA2581025C Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
| 06/07/2011 | CA2571318C Nerve regeneration by transplanting cells expressing recombinant transforming growth factor superfamily protein |
| 06/07/2011 | CA2555824C Fused-ring 4-oxopyrimidine derivative |
| 06/07/2011 | CA2551141C Derivatives of n-(1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity |
| 06/07/2011 | CA2490573C Improved transdermal delivery system |
| 06/07/2011 | CA2480026C Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgesics |
| 06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/07/2011 | CA2455774C Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain |
| 06/07/2011 | CA2444634C Spiropyrazole compounds |
| 06/07/2011 | CA2443151C Process for producing nerve stem cells, motor neurons, and gabaergic neurons from embryonic stem cells |
| 06/07/2011 | CA2386515C Piperazine derivatives |
| 06/07/2011 | CA2361496C Ph independent extended release pharmaceutical formulation |
| 06/07/2011 | CA2306216C The use of inhibitors of the renin-angiotensin system for the treatment of cachexia and wasting |
| 06/07/2011 | CA2213759C Method for treating amyloidosis |
| 06/03/2011 | WO2011066378A2 Antagonists of il-6 to prevent or treat thrombosis |
| 06/03/2011 | WO2011066374A2 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| 06/03/2011 | WO2011066371A2 Antibodies to il-6 and use thereof |
| 06/03/2011 | WO2011066285A2 Peptide-based treatment for neurodegenerative diseases |
| 06/03/2011 | WO2011066182A2 Socs3 inhibition promotes cns neuron regeneration |
| 06/03/2011 | WO2011065982A2 Polymorphisms associated with parkinson's disease |
| 06/03/2011 | WO2011065905A1 Solid forms of 4-{(r)-(3-aminophenyl)[4-(4-fluorobenzyl)-piperazin-1-yl]methyl}-n,n-diethylbenzamide, compositions thereof, and uses therewith |
| 06/03/2011 | WO2011065769A2 Cell or culture extract of cladonia macilenta purple and/or biruloquinone as acetylcholinesterase inhibitors |
| 06/03/2011 | WO2011065767A2 Composition for promoting the activity of peroxisome proliferator-activated receptor-δ |
| 06/03/2011 | WO2011065600A1 Use of inhalable powder formulation comprising growth hormone for preventing or treating nmda receptor hypofunction-related diseases |
| 06/03/2011 | WO2011065480A1 Nerve cell death inhibitor |
| 06/03/2011 | WO2011065444A1 Antithrombotic agent |
| 06/03/2011 | WO2011064753A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | WO2011064315A1 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts |
| 06/03/2011 | WO2011064288A1 Morpholinothiazoles as alpha 7 positive allosteric modulators |
| 06/03/2011 | WO2011064274A1 Use of h3 histaminergic agonists for the treatment of addiction to drugs of abuse |
| 06/03/2011 | WO2011064237A1 Crystalline forms of substituted pyrazolopyrimidines |
| 06/03/2011 | WO2011063989A2 Treatment of nerve injuries |
| 06/03/2011 | WO2011063732A1 Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof |
| 06/03/2011 | WO2011042473A3 Estrogen receptor ligands |
| 06/03/2011 | WO2011041920A3 Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin b12 and vitamin b6 and the use thereof for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral ageing |
| 06/03/2011 | WO2011033225A3 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/03/2011 | WO2011014693A3 Bacteriophages expressing amyloid peptides and uses thereof |
| 06/03/2011 | WO2011014613A3 Preparation of fipamezole |
| 06/03/2011 | WO2011008572A3 5-ht3 receptor modulators, methods of making, and use thereof |
| 06/03/2011 | WO2010077925A3 Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate |
| 06/03/2011 | CA2782207A1 Polymorphisms associated with parkinson's disease |
| 06/03/2011 | CA2781744A1 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts |
| 06/03/2011 | CA2780218A1 Morpholinothiazoles as alpha 7 positive allosteric modulators |
| 06/03/2011 | CA2779875A1 Socs3 inhibition promotes cns neuron regeneration |
| 06/03/2011 | CA2776361A1 Crystalline forms of substituted pyrazolopyrimidines |
| 06/02/2011 | US20110131669 Ganglioside epitopes for treating guillain-barre syndrome |
| 06/02/2011 | US20110130466 Use of rasagiline for the treatment of progressive supranuclear palsy |
| 06/02/2011 | US20110130463 Deuterium-enriched bupropion |
| 06/02/2011 | US20110130454 Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
| 06/02/2011 | US20110130452 Store-operated calcium cellular assay |
| 06/02/2011 | US20110130447 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130429 Pyridines for treating injured mammalian nerve tissue |
| 06/02/2011 | US20110130428 Sublingual Compositions Comprising (2S) - (4E) -N-Methyl-5- (3- (5-Isopropoxypyridin) YL)-4-Penten-2-Amine |
| 06/02/2011 | US20110130425 Use of H3 Histaminergic Agonists for the Treatment of Addiction to Drugs of Abuse |
| 06/02/2011 | US20110130424 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 06/02/2011 | US20110130423 Compounds Which Have Activity At M1 Receptor And Their Uses In Medicine |
| 06/02/2011 | US20110130420 Isoquinolinone derivatives as nk3 antagonists |
| 06/02/2011 | US20110130415 Protein kinase c inhibitors and uses thereof |
| 06/02/2011 | US20110130409 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 06/02/2011 | US20110130408 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
| 06/02/2011 | US20110130407 Isoquinolinone derivatives as nk3 antagonists |
| 06/02/2011 | US20110130403 Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
| 06/02/2011 | US20110130399 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 06/02/2011 | US20110130396 Imidazothiadiazole derivatives |
| 06/02/2011 | US20110130395 P13k isoform selective inhibitors |
| 06/02/2011 | US20110130392 Method of Administering a Methylene Blue - Curcumin Analog for the Treatment of Alzheimer's Disease |
| 06/02/2011 | US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/02/2011 | US20110130390 Use of COX-2 Inhibitors for the Treatment of Schizophrenia, Delusional Disorders, Affective Disorders, Autism or Tic Disorders |
| 06/02/2011 | US20110130389 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof |
| 06/02/2011 | US20110130387 Sirtuin modulating compounds |
| 06/02/2011 | US20110130385 Bicyclic Heterocylic Derivatives and Methods of Use |
| 06/02/2011 | US20110130384 Amide compound |
| 06/02/2011 | US20110130383 Use of Ion Channel Modulators in the Prophylaxis and Treatment of Inflammatory and Immunological Diseases |
| 06/02/2011 | US20110130382 Modulators of 5-ht receptors and methods of use thereof |
| 06/02/2011 | US20110130380 Heteroaryl Kinase Inhibitors |
| 06/02/2011 | US20110130379 Piperazine derivatives used as cav2.2 calcium channel modulators |
| 06/02/2011 | US20110130376 New no releasing steroids derivatives |
| 06/02/2011 | US20110130364 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/02/2011 | US20110130362 A2b adenosine receptor antagonists |
| 06/02/2011 | US20110130354 Sulfated oligosaccharide derivatives |
| 06/02/2011 | US20110130337 Polymorphisms associated with parkinson's disease |
| 06/02/2011 | US20110130336 Method of treating ischemic injury using apoaequorin |
| 06/02/2011 | US20110130331 Modified growth hormones |
| 06/02/2011 | US20110130329 Glp-1 Fusion Peptides, Their Production and Use |
| 06/02/2011 | US20110129896 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3Beta PROTEIN AND PROTEIN COMPLEXES |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129543 Fermented plant extracts, methods of production and uses |
| 06/02/2011 | US20110129541 Suspension delivery system for the sustained and controlled local release of pharmaceuticals |